Brighter and Al Zahra hospital in Dubai have entered into a Commercial Partnership Regarding Actiste
Brighter AB (publ) announced today that its subsidiary Brighter Software Trading LLC has entered into a commercial partnership with Al Zahra Hospital in Dubai regarding the implementation of Brighter's diabetes solution Actiste® (the "Actiste service"). Brighter and Al Zahra are initially aiming to achieve 100 subscriptions for Actiste® and Actiste® Mini with an estimated launch as soon as all data storage and telecom-related product and market preparations have been completed.
Through the partnership, Al Zahra Hospital will become a direct channel for Brighter to reach potential Actiste® users in the United Arab Emirates.
Al Zahra Hospital Dubai, with a medical team of over 250 doctors and more than 400 nurses, was founded in 2013, with the objective of providing superior medical care and comfort through the use of state-of-the-art technology and equipment combined with world-class medical experts. The hospital is accredited by the Joint Commission International and has various prestigious certifications from international accreditation bodies around the world.
"Al Zahra Hospital Dubai is a successful private healthcare provider providing the highest quality of medical care to both local and international residents of the United Arab Emirates. We are very happy to have them as a partner in our journey to improve the lives of people living with diabetes in the region,” says Christer Trägårdh, interim CEO of Brighter.
About Actiste
The Actiste® product portfolio (“Actiste Service”) is based on a concept the company refers to as “The Benefit Loop” - a personal, holistic and data-centered approach to healthcare. The service includes a unique unified care device for monitoring, supporting, and treating diabetes (Actiste®) or (Actiste® Mini). The devices have global out-of-the-box connectivity via eSIM technology making them completely independent of other units to save and utilize data. Combined with a digital platform for daily support and management, and automatic replenishment of needed consumables, Actiste service is designed to simplify the everyday life for people living with diabetes aiming to support improvement of treatment adherence, to increase healthcare providers’ access to real-world treatment data for better treatment advice, and ultimately to facilitate better health outcomes. https://actiste.com/
For more information, please contact:
Investor Relations
ir@brighter.se
Certified Adviser
Brighter's Certified Adviser is Eminova Fondkommission AB, +46 [0)8 - 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. https://brighter.se/